Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Triantos

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|January 26, 2012
Meta-analysis: antiviral treatment for hepatitis DC Triantos, M Kalafateli, V Nikolopoulou, et al.
Journal of Viral Hepatitis|July 7, 2015
Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarateG Papatheodoridis, C Triantos, E Hadziyannis, et al.
Journal of Viral Hepatitis|August 5, 2008
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studiesE Xirouchakis, C Triantos, P Manousou, et al.
Gut|April 26, 2006
Transjugular liver biopsy: how good is it for accurate histological interpretation?E Cholongitas, A Quaglia, D Samonakis, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2007
Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varicesJ Vlachogiannakos, A Kougioumtzian, C Triantos, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcomeS Manolakopoulos, S Bethanis, J Elefsiniotis, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2005
Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligationC Triantos, J Vlachogiannakos, A Armonis, et al.
Journal of Viral Hepatitis|November 15, 2013
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirinA Striki, S Manolakopoulos, M Deutsch, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2009
Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre studyE Tsochatzis, S Manolakopoulos, G V Papatheodoridis, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2007
Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudineS Manolakopoulos, S Bethanis, S Koutsounas, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|January 26, 2012
Meta-analysis: antiviral treatment for hepatitis DC Triantos, M Kalafateli, V Nikolopoulou, et al.
Journal of Viral Hepatitis|July 7, 2015
Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarateG Papatheodoridis, C Triantos, E Hadziyannis, et al.
Journal of Viral Hepatitis|August 5, 2008
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studiesE Xirouchakis, C Triantos, P Manousou, et al.
Gut|April 26, 2006
Transjugular liver biopsy: how good is it for accurate histological interpretation?E Cholongitas, A Quaglia, D Samonakis, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2007
Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varicesJ Vlachogiannakos, A Kougioumtzian, C Triantos, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcomeS Manolakopoulos, S Bethanis, J Elefsiniotis, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2005
Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligationC Triantos, J Vlachogiannakos, A Armonis, et al.
Journal of Viral Hepatitis|November 15, 2013
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirinA Striki, S Manolakopoulos, M Deutsch, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2009
Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre studyE Tsochatzis, S Manolakopoulos, G V Papatheodoridis, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2007
Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudineS Manolakopoulos, S Bethanis, S Koutsounas, et al.
Pageof 1